Effect of CRMP3 expression on dystrophic dendrites of hippocampal neurons

Molecular Psychiatry

Volumn 16, Issue 7, 2011, Pages 689-691

  Quach, T T ^a   Wang, Y ^b   Khanna, R ^b   Chounlamountri, N ^a   Auvergnon, N ^a   Honnorat, J ^a,c   Duchemin, A M ^d  

^a UNIVERSITÉ LYON 1   (France)

^b INDIANA UNIVERSITY   (United States)

^c HÔPITAL NEUROLOGIQUE   (France)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE PROTEIN; PRION PROTEIN; PROTEIN CRMP3; UNCLASSIFIED DRUG;

BRAIN NERVE CELL; DENDRITIC DYSTROPHY; HIPPOCAMPUS; HUMAN; LETTER; NEUROPATHY; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79959598309     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.6     Document Type: Letter

References (11)

1. Quach TT, Glasper ER, Devries AC, Honnorat J, Kolattukudy PE, Duchemin AM. Mol Psychiatry 2008; 13: 656-658.
2. Quach TT, Massicote G, Belin MF, Honnorat J, Glasper ER, Devries AC, et al. FASEB J 2008; 22: 401-409.
3. Quach TT, Rogemond V, Chounlamountri N, Brot S, Kollattukudy PE, Belin MF, et al. Submitted for publication.
4. Chongsuk R. J Microbiol Biotechnol 2007; 17: 1059-1070.
5. Gu Y, Fujioka H, Mishra RS, Li R, Singh N. J Biol Chem 2002; 277: 2275-2286.
6. Bell A, Gentleman G, Ironside JW, Mc Cardle L, Lantos PL, Doey L, et al. Neuropathol Appl Neurobiol 1997; 23: 26-35.
7. Moore SJ, Simmons M, Chaplin M, Spiropoulous J. Acta Neuropathol 2008; 116: 547-559.
8. Kaneko M, Sugiyama N, Sasayama D, Yamaoka K, Miyakawa T, et al. Psychiatry Clin Neurosci 2008; 62: 264-270.
9. Konur S, Ghosh A. Neuron 2005; 29: 3288-3301.
10. Thellung S, Florio T, Villa V, Corsaro A, Arena S, Amico C, et al. Neurobiol Dis 2000; 7: 299-309.
11. Sandberg MK, Wallén P, Wikström MA, Kristensson K. Neurobiol Dis 2004; 15: 143-151.